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http://www.biomedcentral.com/1471-244X/14/187RESEARCH ARTICLE Open AccessPain, not chronic disease, is associated with the
recurrence of depressive and anxiety disorders
Marloes MJG Gerrits1,2*, Patricia van Oppen1,2, Stephanie S Leone2, Harm WJ van Marwijk2,
Henriëtte E van der Horst2 and Brenda W Penninx1,3,4Abstract
Background: Studies suggest that poor physical health might be associated with increased depression and
anxiety recurrence. The objectives of this study were to determine whether specific chronic diseases and pain
characteristics are associated with depression and anxiety recurrence and to examine whether such associations
are mediated by subthreshold depressive or anxiety symptoms.
Methods: 1122 individuals with remitted depressive or anxiety disorder (Netherlands Study of Depression and
Anxiety) were followed up for a period of four years. The impact of specific chronic diseases and pain characteristics
on recurrence was assessed using Cox regression and mediation analyses.
Results: Chronic diseases were not associated with recurrence. Neck (HR 1.45, p < .01), chest (HR 1.65, p < .01),
abdominal (HR 1.52, p < .01) pain, an increase in the number of pain locations (HR 1.10, p < .01) and pain severity
(HR 1.18, p = .01) were associated with an increased risk of depression recurrence but not anxiety. Subthreshold
depressive symptoms mediated the associations between pain and depression recurrence.
Conclusions: Pain, not chronic disease, increases the likelihood of depression recurrence, largely through its
association with aggravated subthreshold depressive symptoms. These findings support the idea of the existence of
a mutually reinforcing mechanism between pain and depression and are indicative of the importance of shedding
light on neurobiological links in order to optimize pain and depression management.
Keywords: Depressive disorder, Anxiety disorder, Recurrence, Pain, Chronic diseasesBackground
Depressive and anxiety disorders are often recurrent. Re-
currence rates of 25 to 60% have been reported in studies
on different populations and using various methodologies
[1-11]. After two to three years in remission, recurrence
rates seem to stabilize after a person stays well for a longer
period, the risk of recurrence is diminished [1,7,12].
Insight into risk factors for the recurrence of depressive
and anxiety disorders is necessary in order to identify
strategies to prevent new episodes as well as individuals
who might benefit from long-term treatment [13].* Correspondence: mj.gerrits@vumc.nl
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University Medical Center and Academic Outpatient Clinic for Affective
Disorders, GGZ inGeest, Amsterdam, The Netherlands
2Department of General Practice and Elderly Care Medicine, EMGO Institute
for Health and Care Research, VU University Medical Center, Van der
Boechorststraat 7, 1081 BT Amsterdam, The Netherlands
Full list of author information is available at the end of the article
© 2014 Gerrits et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.Chronic diseases and/or pain might pose an import-
ant -potentially modifiable - risk for recurrence of de-
pressive and anxiety disorders for various reasons [14].
Firstly, a negative impact for several chronic diseases
and pain on the prevalence, the course of illness and
treatment outcome for depression and anxiety was pre-
viously assessed [15-24]. Secondly, chronic diseases and
pain can lead to negative coping strategies, disability
and reduced quality of life [25,26], which might in turn
lead to a further depressive or anxiety episode. Finally,
shared pathophysiological mechanisms have been pos-
tulated for chronic somatic diseases and pain, on the
one hand, and depression and anxiety, on the other
[27-29]. So far, there is limited evidence for the effect
of chronic diseases, especially specific diseases, and
pain on depression and anxiety recurrence [30]. One
study found that higher pain severity predicted depres-
sion relapse in 278 randomized trial subjects [31]. ALtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ratings significantly impacted depression relapse (n = 128)
[32], whereas another found no effect for chronic condi-
tions (n = 251) [8]. Two longitudinal studies (n = 585, n =
687 respectively) found that chronic diseases [3,4] and
chronic pain [3] did not predict depression recurrence.
One study (n = 429) found no effect for the number of
chronic diseases on anxiety recurrence in a multivariate
model [33]. To the best of our knowledge, there are no
studies reporting associations between pain and anxiety
recurrence. Previous studies on risk factors for recurrence
of depressive and anxiety disorders point to subthreshold
depressive and anxiety symptoms as the most consistent
predictive factors for depression and anxiety recurrence
[1-6,8-10,13,22,31,34-36]. Since chronic diseases and pain
can also contribute to subthreshold depressive and anxiety
symptoms [37,38], chronic diseases and pain and recur-
rence of depressive and anxiety disorders may be linked
through higher subthreshold depressive and anxiety levels.
The objectives of this study were to examine to what
extent chronic disease in general and specific diseases
and pain symptoms are associated with recurrence of
depressive and anxiety disorders in patients with a prior
history of a depressive and/or anxiety disorder in a
major longitudinal study. And second, to determine
whether subthreshold depressive and anxiety symptoms
partly mediate associations between chronic diseases
and pain, on the one hand, and recurrence of depressive
and anxiety disorders, on the other.
Methods
Sample
The Netherlands Study of Depression and Anxiety
(NESDA) is a longitudinal cohort study, which was de-
signed to examine the long-term course and conse-
quences of depressive and anxiety disorders [39]. At
baseline, 2981 participants (18 to 65 years), were in-
cluded from the general population (n = 564), general
practices (n = 1610) and mental health care organiza-
tions (n = 807). Exclusion criteria were not being fluent
in Dutch and having a primary diagnosis of psychotic,
obsessive compulsive, bipolar or severe addiction dis-
order. The Ethical Committee of the participating uni-
versities approved the research protocol and written
informed consent was obtained from all patients. Base-
line data collection took place between 2004 and 2007,
with follow-up assessments, including the CIDI, two and
four years later. The face-to-face interview assessments
included a standardized diagnostic psychiatric interview
and demographic and personal characteristics. Specially
trained research staff conducted the interviews.
All 2981 participants were screened for depression and
anxiety at baseline using the DSM-IV based Composite
International Diagnostic Interview (CIDI, Version 2.1), ahighly reliable and valid instrument for assessing depres-
sive (major depressive disorder, dysthymia) and anxiety
(social phobia, generalized anxiety disorder, panic dis-
order, agoraphobia) disorders [40]. Participants could
have either no history, a prior history or a current
depressive and/or anxiety disorder.
For this study, we examined 1236 participants who
reported to have had a depressive or anxiety disorder in
the past, but were currently in remission according to
the CIDI, which meant they did not have a diagnosis of
a depressive or anxiety disorder (in the previous six
months) either at baseline (n = 628) or at the two year
follow-up assessment (n = 608). Of these, 114 (9.2%),
who did not differ significantly in age, gender, education
or subthreshold depressive or anxiety symptoms at base-
line, did not participate in the follow-up assessments.
Consequently, a total of 1122 participants were followed
up for up to four years.
Recurrence of depressive and anxiety disorders
Recurrence of a depressive or anxiety disorder (yes/no)
was defined by the DSM-IV based CIDI in the subse-
quent assessments. We calculated the time to recurrence
of a depressive or anxiety disorder in months (maximum
of 48 months) from the time the participant was
assessed as being in remission (did not have a current
diagnosis) until they were diagnosed with a depressive or
anxiety disorder in one of the follow up assessments ac-
cording to the CIDI. When a participant was diagnosed
with a recurrence at the 2- or 4-year follow up assess-
ment, participants were asked to indicate the recency of
onset: less than a month ago, between one and 6 months
ago, between 6 and 12 months ago, 12 months ago and
between 12 and 24 months ago retrospectively. We used
this information to calculate the median of the interval
to recurrence. For instance, if a participant reported a
recurrence of depressive or anxiety disorder between 1
and 6 months ago (median 3 months ago) at the 4-year
follow up interview (and no disorder at the two year fol-
low up), the time from baseline to recurrence to be used
in the analyses was (48-3=) 45 months. For participants
with no recurrence of depression or anxiety, time was
censored as the time from the assessment in which remis-
sion was defined until the end of the follow up period.
Measurements
Data on self-reported chronic diseases and pain, both
indicators of physical health, were assessed at the point
at which the participants were in remission (either at
baseline or at the two-year follow up assessment).
Chronic disease
First, patients were asked in a face-to-face interview
whether they had been diagnosed with any of the chronic
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the most objective assessment of chronic diseases, we only
deemed chronic disease to be present if the participant
stated that the disease was being treated by a healthcare
professional or he or she was using medication for the
disease. As in a previous study [18], we classified chronic
diseases into seven main categories; cardiometabolic,
respiratory, endocrine, neurological, musculoskeletal,
digestive disorders and cancer. We defined the number
of chronic diseases as the number of disease categories
into which a participant fell.
Pain
To assess pain over the last 6 months, the interview con-
tained four different items: a) 7 specific common pain
locations (neck, back, head, orofacial area, abdomen,
chest and joints); b) the number of locations; c) duration
and; d) severity determined by the Chronic Pain Grade
(CPG) [41]. First, the number of pain locations (0–7) in
the last six months was assessed. Then, the participant
was asked to choose the most painful site, to which all sub-
sequent questions applied. Next, duration of pain in the
last six months was dichotomized as ≥90 versus <90 days,
based on the most frequently used definition of chronic
pain. Last, severity was graded by measuring the intensity
of pain and disability caused by pain using the CPG scale:
– Grade 1: low intensity-low disability
– Grade 2: high intensity-low disability
– Grade 3: high disability-moderately limiting
– Grade 4: high disability-severely limiting
To exclude mild and sporadic pain symptoms experi-
enced in the past six months, only pain locations with at
least a Grade 2 on the CPG were taken into account.
Only the more severe pain locations (at least high inten-
sity of pain and low disability caused by pain) were
included.
Covariates
Sociodemographic characteristics included age, gender
and number of years in education. The recency of the
last episode of depressive or anxiety disorder, more than
one year ago or one year or less, was determined at the
time participants were deemed to be in remission from
a depressive or anxiety disorder, since the time from
remission might impact on the recurrence of depression
and anxiety [1]. Additionally, to account for possible
psychoactive and pain medication effects, medication
use was assessed based on drug container inspection of
all drugs used in the month prior to the interview and
classified according to the World Health Organization
Anatomical Therapeutic Chemical (ATC) classification.
Antidepressants included selective serotonin reuptakeinhibitors (ATC-code N06AB), tricyclic antidepressants
(N06AA) and other antidepressants (N06AF/N06AX).
Benzodiazepines included ATC-codes N03AE, N05BA,
N05CD and N05CF. Pain medication included paraceta-
mol (N02BE01), acetylsalicylic acid (N02BA), non-steroidal
anti-inflammatory drugs (M01A, M01B), and opioids
(N02A).Mediators
A mediator is an intervening variable that may account
for the association between the independent variables,
chronic disease and pain, and the dependent variable,
the recurrence of depression or anxiety. We assessed
the subthreshold symptoms of depression and anxiety
using the severity of symptoms at the time participants
were deemed to be in remission from depressive or anx-
iety disorders. We expected subthreshold symptoms to
be partial mediators since the presence of chronic
diseases and pain have been shown to increase severity
of symptoms of depression and anxiety [37,38], which
could in turn lead to depression or anxiety recurrence
[1-3,5,6,8,10,31,34,35]. The severity of depressive symp-
toms was measured using the Quick Inventory of De-
pressive Symptomatology -self-report (QIDS), a reliable
and valid instrument consisting of 16 items (0–27 score)
[42,43]. Self-reported anxiety symptom severity was
measured using the reliable and valid Beck Anxiety
Inventory (BAI), consisting of 21 items (0–63 score),
measuring severity of mainly arousal-related symptoms
of anxiety [44].Statistical analysis
To examine the associations of chronic diseases and
pain with the time to recurrence of a diagnosis of
depression or anxiety, we performed Cox regression
analyses, before and after adjustment for covariates. Cox
regression takes into account differences in time at risk
for an event and censoring. Time at risk was measured
from the moment the participant was assessed as being
in remission until either the participant had an event, a
recurrent depressive or anxiety disorder, or was censored
when the participant did not have a recurrence during
the follow up period. We also analyzed the time to
recurrence of depressive and anxiety disorder separately,
in order to explore whether the impact of chronic dis-
eases and pain is different for recurrence of depression
versus anxiety.
To determine whether subthreshold symptoms of
depression and anxiety mediated the associations found
between chronic diseases, pain and recurrence of de-
pression or anxiety, we conducted mediation analyses,
through the indirect method by Preacher and Hayes
involving bootstrapping approximations (Figure 1) [45].
Table 1 Sample characteristics
Characteristics Population
N = 1122 (%)
Sample characteristics
Female gender,% 765 (68.2%)
Age in years, Mean (SD) 43.4 (12.8)
Education in years, Mean (SD) 12.5 (3.2)
Recency of last episode (≤1 year),% 160 (14.3%)
History of both depression and anxiety,% 543 (48.4%)
QIDS score, Mean (SD) 5.4 (3.7)








Asthma, chronic bronchitis, pulmonary emphysema 88 (7.8%)
Musculoskeletal




Ulcer, irritable bowel syndrome, Crohn’s disease,








Thyroid dysfunction 36 (3.2%)
Cancer
Throat, thyroid, lymphoid, lung, esophagus, bowel,
stomach, liver, uterus, cervix, ovary, bladder, testicle,
prostate, skin, brain, blood
83 (7.4%)









Number of pain locations, Mean (SD)1 1.2 (1.9)
Duration of Pain ≥ 90 days,% 355 (31.6%)
Chronic Pain Grade (CPG)
CPG 0-1 720 (64.2%)
CPG 2 246 (21.9%)
CPG 3 101 (9.0%)
Table 1 Sample characteristics (Continued)
CPG 4 54 (4.8%)
Outcome,%
Recurrence of depression disorder 292 (26.0%)
Recurrence of anxiety disorder 255 (22.7%)
Recurrence of depressive and/or anxiety disorder 424 (37.8%)
Duration of follow up in months, Mean (SD) 30.0 (13.4)
1Pain locations were only taken into account when CPG ≥ 2.
Abbreviations: CPG Chronic Pain Grade, QIDS Quick Inventory of Depressive
Symptoms, BAI Beck Anxiety Inventory.
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estimates the total, direct, and indirect unstandardized
effects of the independent variables on the dependent
variable through the mediator variable, controlling for
covariates. The results will show the effect “a” of the
independent variable (pain variable) on the mediating
variable (depression severity), and the effect “b” of the
mediating variable on the dependent outcome (depres-
sion recurrence). The effect of the pain variables on the
recurrence of a depressive disorder will be shown by the
direct “c’” effect. The effect of the pain variables on
the recurrence of a depressive disorder through depres-




Table 1 shows the characteristics of the study sample (n =
1122). Mean age of the study sample was 43.4 years and
68.2% were female. The average number of chronic
diseases was 0.6 (SD 0.8), 59.4% of participants had no
chronic disease. The mean number of pain locations was
1.2 (SD 1.9) and 35.8% had a CPG of at least 2. Of the
participants, 424 (37.8%) experienced a recurrence of a
depressive and/or anxiety disorder during the follow-up
period. Of participants with a least one chronic disease
39.1% had a recurrence, whereas participants with severe
or disabling pain (CPG > =2) 42.4% had a recurrence.
When considering depression and anxiety recurrence
separately, 26.0% and 22.7% participants had a recurrence,
respectively. For depression recurrence, participants with
severe or disabling pain (CPG > =2) were more likely to
experience a recurrence; 30.9%. The average follow-up
period was 30.0 months (SD 13.4).
Impact of chronic diseases and pain on recurrence
Table 2 shows the adjusted associations between chronic
diseases, pain symptoms and recurrence of a depressive
or anxiety disorder. Unadjusted analyses showed similar
results (not shown). For the chronic disease categories
no associations were found for recurrence of depression
or anxiety. Significant positive associations were found
Independent 
variable (IV):
Effect IV on M: a Effect M on DV: b
Direct effect = c’





Figure 1 Mediation model. A = effect of independent variable on mediating variable. B = effect of mediating variable on dependent outcome.
C = direct effect of independent variable on dependent variable. C’ = total effect of independent variable on dependent variable. AxB = indirect
effect of independen variable on dependent variable through mediating variable.
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such associations were solely driven by the recurrence of
depressive disorder, not anxiety. For instance, neck pain
was significantly associated with 45% increased risk for
depression recurrence (HR 1.45, p = .005). Similarly,
chest (HR = 1.65, p = .008) and abdominal (HR = 1.52,
p = .003) pain were significantly associated with depres-
sion recurrence, as was the number of pain locations
(per location increase: HR = 1.10, p = .002) and higher
CPG (per grade increase: HR = 1.18, p = .01). Addition-
ally adjusting for use of psychotropic or pain medication
did not alter the results.Mediation of subthreshold depressive and anxiety
symptoms
In Table 3, we show the mediation of subthreshold
depressive symptoms on the associations between pain
and recurrence of depression which were analysed as
borderline significant or significant in the Cox regression
analyses (p < .10). We did not conduct these analyses for
chronic diseases or recurrence of anxiety, since we did
not find any significant associations for these indicators
in initial analyses. First, mediation analyses confirmed
that pain is associated with higher severity of subthresh-
old symptoms (a in Table 3) and that a higher severity of
subthreshold symptoms was significantly associated with
depression recurrence (b in Table 3). For all pain vari-
ables, the direct paths were assessed as insignificant,
although the direct paths of abdominal and chest pain
remained borderline significant (c’ in Table 3). The indir-
ect effects (a × b in Table 3) were significant for pain of
the neck, back, head, abdomen, chest and joints, higher
number of pain locations and higher CPG, suggesting
that there is an overall effect of the pain variables on
depression recurrence through aggravated subthreshold
depressive symptoms.Discussion
The purpose of this study was to examine whether
chronic diseases and pain are associated with recurrence
of depressive and anxiety disorders and if so, whether
these associations are partly mediated by subthreshold
depressive and anxiety symptoms. In this large study
with a mean follow up of 2,5 years, 37.8% of people
experienced a recurrence, which corresponds reasonably
well to recurrence rates found in previous research
[1-11]. During follow-up a quarter of all participants had
a depression recurrence, while a third of participants
with severe or disabling pain had a recurrence. We did
not detect an association between chronic disease and
recurrence of depressive and anxiety disorders. Severe
neck, chest and abdominal pain, a higher number of
pain locations and higher pain severity of pain were sig-
nificantly associated with recurrence of depressive dis-
order, but not anxiety. Subthreshold depressive symptoms
mediated the associations between pain and depression
recurrence.
The finding that chronic diseases are not associated
with the recurrence of depression or anxiety in this
study is in line with previous studies [3,4,8,33]. Iosifescu
et al. found that increasing cumulative chronic disease
ratings did predict relapse in a treatment trial [32].
Contrary to the measurements used by Iosifescu et al.,
we had no information on the severity of the chronic
diseases and our study was based on a relatively healthy
population with on average 0.6 chronic diseases. Also,
the present study and the above mentioned studies
investigated rather young populations with mean age
around forty years [3,4,8,32]. Chronic diseases often pro-
gress over time so associations with depression and anx-
iety recurrence might be different in studies examining
older multi-morbid populations.
This is the first observational study to systematically
examine the associations between pain symptoms and
Table 2 Associations between somatic health variables and time to recurrence of depressive and/or anxiety disorder
during follow-up (n = 1122)a
Physical health
characteristics






HR (95% CI) p HR (95% CI) p HR (95% CI) p
Chronic disease category
Cardiometabolic 0.94 (0.71-1.25) .66 0.86 (0.61-1.21) .38 1.11 (0.78-1.59) .57
Respiratory 1.17 (0.84-1.65) .36 1.31 (0.89-1.93) .18 1.10 (0.70-1.71) .69
Musculoskeletal 1.13 (0.83-1.55) .44 1.35 (0.94-1.92) .11 1.19 (0.80-1.77) .39
Digestive 1.26 (0.92-1.73) .15 1.19 (0.82-1.75) .36 1.22 (0.81-1.84) .34
Neurological 1.17 (0.74-1.86) .50 1.22 (0.71-2.09) .47 0.89 (0.46-1.74) .74
Endocrine 1.09 (0.65-1.83) .76 1.07 (0.57-2.02) .84 1.53 (0.85-2.75) .15
Cancer 1.13 (0.80-1.60) .49 1.11 (0.73-1.68) .62 1.21 (0.78-1.86) .40
Number of chronic diseases 1.09 (0.97-1.23) .16 1.11 (0.96-1.27) .16 1.13 (0.97-1.31) .12
Pain location b
Neck 1.31 (1.05-1.64) .02 1.45 (1.12-1.89) .005 1.15 (0.86-1.55) .35
Back 1.15 (0.93-1.43) .21 1.30 (1.00-1.67) .05 0.93 (0.70-1.24) .65
Head 1.21 (0.98-1.50) .08 1.29 (1.00-1.67) .05 1.26 (0.95-1.66) .11
Orofacial 1.34 (0.92-1.96) .13 1.46 (0.94-2.27) .09 1.20 (0.72-2.00) .49
Chest 1.51 (1.09-2.08) .01 1.65 (1.14-2.39) .008 1.41 (0.93-2.14) .11c
Abdominal 1.33 (1.05-1.68) .02 1.52 (1.16-2.02) .003 1.13 (0.82-1.55) .45
Joints 1.20 (0.96-1.51) .12 1.31 (1.00-1.71) .05 0.99 (0.73-1.34) .94
Number of pain locationsb 1.07 (1.02-1.12) .009 1.10 (1.04-1.16) .002 1.03 (0.97-1.10) .34
Duration of pain≥ 90 days 1.10 (0.89-1.35) .38 1.24 (0.96-1.58) .11 0.99 (0.75-1.30) .94
Chronic Pain Grade 1.11 (0.99-1.24) .06 1.18 (1.04-1.35) .01 1.07 (0.93-1.24) .35
aUsing univariate cox regression analyses.
bPain locations were only taken into account when CPG ≥ 2.
cAdjusted for age, gender, years of education and recency of last episode of depressive or anxiety disorder.
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eral pain characteristics are associated with a higher risk
of depression recurrence, which concurs with results of
Fava et al. who found that higher levels of pain severity
predicted relapse of depression in trial subjects [31].Table 3 Summary of Preacher and Hayes mediator model ana



















Number of pain locations1 .
Chronic Pain Grade .
*p < .05, **p < .001, ^ significant based on 95% confidence interval (CI).
1Pain location was only taken into account when CPG ≥ 2.
2Adjusted for age, gender, years of education and recency of last episode of depresSince all pain locations were found to be borderline sig-
nificant or significant, the particular location of the pain
seems less relevant in predicting depressive disorder re-
currence. Our results point to a dose–response relation-
ship, where increasing number of pain locations andlyses (5000 bootstraps) between pain (IV), and













Effect p Effect p
.55** .16** .25 .14 .25 (.14-.36)^ .47 .004
.40** .16** .05 .76 .23 (.13-.34)^ .27 .09
.25** .16** .12 .48 .20 (.11-.31)^ .30 .05
.79** .16** .35 .06 .28 (.17-.41)^ .60 .001
.51** .16** .43 .10 .40 (.23-.59)^ .77 .002
.21** .16** .16 .37 .19 (.10-.30)^ .34 .04
42** .15** .06 .12 .07 (.04-.09)^ .12 .001
74** .16** .08 .36 .12 (.07-.18)^ .18 .02
sive and/or anxiety disorder.
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pression recurrence. Our findings, with subthreshold de-
pression levels largely mediating the associations, indicate
that a mutually reinforcing mechanism between pain and
depression might exist [27]. In support of such relation-
ship, another study found that change in pain was a strong
predictor of subsequent depression symptom severity and
vice versa [46]. A vicious circle could arise with negative
coping strategies in response to impaired physical and so-
cial role functioning caused by both the pain and affective
symptoms [47,48]. Furthermore, evidence for various
shared pathophysiological pathways has been found. Neu-
roimaging studies have shown overlap of the neuronal
networks of emotion and pain, particularly in the (pre)
frontal cortical regions [49]. Pain may cause changes such
as dysregulation of the HPA axis (increasing cortisol
levels), and of the autonomic nervous system (increased
sympathetic or decreased parasympathetic function) lead-
ing to a new depressive disorder episode. It might also
be possible that through these same pathways, previous
depressive episode(s) have made patients more vulnerable
to pain [22,27,47,50-52].
Contrary to what we expected, we did not find a
significant relationship between pain and anxiety recur-
rence. Although the same pathophysiological pathways
for depression and pain are mentioned in research on
anxiety and pain, associations might be different or they
might be linked through depressive disorders. For in-
stance, HPA-axis abnormalities were found to be strongly
associated with depressive disorder and co-morbid depres-
sion and anxiety, but were not present for most types of
anxiety disorders [52,53]. A cross-sectional study found
that depression partly mediated the relationship between
pain and anxiety [21]. A previous NESDA study found
that anxiety predicted the recurrence of anxiety only,
whereas depression predicted the recurrence of both
depression and anxiety [54]. Since research on anxiety
and co-morbid depressive and anxiety disorders is still
limited compared with depressive disorder alone, more
research, particularly on anxiety, is needed to further
explore such links.
This study shows that pain makes a patient vulnerable
to recurrence of depressive disorders. Pain is among the
most common reasons to consult a physician, so patients
with pain who also have a depressive history are very
likely to contact their physician. The physician then has
the opportunity to enquire after depressive symptoms
and start treatment, if necessary. Previous studies have
shown that pain negatively impacts depression treatment
and vice versa [27,55]. The current study suggests that it
may be of benefit to prolong depression treatment until
full remission, especially for those patients who also ex-
perience severe pain symptoms, as they are a risk group
to remit into full-blown disorders. Also, specific relapseprevention trials could focus on distinctions between pa-
tients with and without pain in order to find new strat-
egies to prevent depression relapse in patients with pain.
Some evidence has been found for alleviating chronic
pain and depressive symptoms with collaborative care
initiatives for chronic pain patients [56,57]. Collaborative
care trials have proven their efficacy on sustained recovery
of depressive disorder and continuation and maintenance
therapies can reduce recurrence [58,59]. Tailored collab-
orative care interventions with maintenance therapies for
patients who recovered from a depressive disorder but
who are experiencing pain might reduce recurrence risk
in this particular subpopulation of vulnerable patients.
Based on ever growing evidence on shared neurobiological
pathways new effective interventions need to be explored.
Strengths of our study are the large sample size, the
prospective design and the systematic investigation of
the role of various chronic diseases and pain on the
recurrence of both depression and anxiety. Also, we
used full diagnostic interviews to assess the presence of
depressive and anxiety disorders with questions on the
recency of episodes which enabled us to assess time to
recurrence more accurately. This study also had some
limitations. The prevalences of specific chronic diseases
(myocardial infarction, epilepsy etc.) were quite low, so
our capacity to study the role of all diseases individually
was limited. This study was conducted with patients of
18 to 65 years old; findings could be different in popula-
tions with younger individuals or elderly people. We
analysed depressive and anxiety disorders separately, but
did not analyse differences between specific depressive
or anxiety disorders. The mediating variable, depressive
symptoms, may partly measure the same construct as
the outcome variable. The final limitation is that the
statistical mediation model assumes temporal direction
of the independent variable preceding the mediator,
which precedes the outcome variable, but both pain and
subthreshold symptoms were measured at the same
assessment.Conclusions
The presence of chronic diseases does not increase the
risk of recurrence of depressive or anxiety disorders.
Pain increases the likelihood of the recurrence of depres-
sive disorder. Since pain was associated with increased
subthreshold depressive symptoms, this largely mediated
the effects. Mutually reinforcing neurobiological mecha-
nisms between pain and depressive disorders are likely
to exist, which might be addressed in future treatment
options, to prevent recurrences.Competing interests
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